E-LIB Suche - Ergebnisse für: Ghislain, Pierre-Dominique

1

Real-Life Effectiveness and Tolerance of Baricitinib for th..:

De Greef, Axel ; Thirion, Romane ; Ghislain, Pierre-Dominique.
Dermatology and Therapy. 13 (2023) 11 - p. 2869-2877 , 2023

Link: https://doi.org/10.1007/..

2

40351 Disease severity in moderate-to-severe plaque psorias..:

Hillary, Tom ; Ghys, Liesbeth ; Willaert, Fabienne...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB37 , 2023

Link: https://doi.org/10.1016/..

3

Real-Life Experience of Tralokinumab for the Treatment of A..:

De Greef, Axel ; Ghislain, Pierre-Dominique ; Bulinckx, Audrey...
Clinical Drug Investigation. 43 (2023) 4 - p. 299-306 , 2023

Link: https://doi.org/10.1007/..

4

Secukinumab in Pediatric Patients with Plaque Psoriasis: Po..:

Sticherling, Michael ; Nikkels, Arjen F. ; Hamza, Ashraf M....
American Journal of Clinical Dermatology. 24 (2023) 5 - p. 821-835 , 2023

Link: https://doi.org/10.1007/..

5

Prolonged real-life experience with baricitinib in patients..:

De Greef, Axel ; Ghislain, Pierre-Dominique ; Baeck, Marie
European Journal of Dermatology. 33 (2023) 6 - p. 707-709 , 2023

Link: https://doi.org/10.1684/..

6

Correction to: Real-Life Effectiveness of Apremilast for th..:

Ghislain, Pierre-Dominique ; Lambert, Jo ; Lam Hoai, Xuãn-Lan...
Advances in Therapy. 40 (2023) 7 - p. 3279-3280 , 2023

Link: https://doi.org/10.1007/..

7

Real-Life Effectiveness and Tolerance of Upadacitinib for S..:

De Greef, Axel ; Ghislain, Pierre-Dominique ; de Montjoye, Laurence.
Advances in Therapy. 40 (2023) 5 - p. 2509-2514 , 2023

Link: https://doi.org/10.1007/..

8

Real-Life Effectiveness of Apremilast for the Treatment of ..:

Ghislain, Pierre-Dominique ; Lambert, Jo ; Lam Hoai, X. L....
Advances in Therapy. 39 (2022) 2 - p. 1068-1080 , 2022

Link: https://doi.org/10.1007/..

9

Efficacy and safety of baricitinib in combination with topi..:

Bieber, Thomas ; Reich, Kristian ; Paul, Carle...
British Journal of Dermatology. 187 (2022) 3 - p. 338-352 , 2022

Link: https://doi.org/10.1111/..

10

Effectiveness and tolerability of guselkumab in patients wi..:

Ghislain, Pierre-Dominique ; Failla, Valérie ; Lambert, Jo...
JAAD International. 4 (2021) - p. 15-17 , 2021

Link: https://doi.org/10.1016/..

11

Secukinumab Use in Patients with Moderate to Severe Psorias..:

Kiltz, Uta ; Sfikakis, Petros P. ; Gaffney, Karl...
Advances in Therapy. 37 (2020) 6 - p. 2865-2883 , 2020

Link: https://doi.org/10.1007/..

12

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis:

, In: Evidence-Based Dermatology,

Roujeau, Jean-Claude ; Ghislain, Pierre-Dominique ; Valleyrie-Allanore, Laurence - p. 578-585 , 2014

Link: https://doi.org/10.1002/..

13

Alopecia areata occurring during anti-TNF therapy: A nation..:

Tauber, Marie ; Buche, Sébastien ; Reygagne, Pascal...
Journal of the American Academy of Dermatology. 70 (2014) 6 - p. 1146-1149 , 2014

Link: https://doi.org/10.1016/..

14

Clinical, Quality of Life, Patient Adherence, and Safety Ou..:

Swimberghe, Sandra ; Ghislain, Pierre-Dominique ; Daci, Evis...
Annals of Dermatology. 25 (2013) 1 - p. 28 , 2013

Link: https://doi.org/10.5021/..

15

Allopurinol is the most common cause of Stevens-Johnson syn..:

Halevy, Sima ; Ghislain, Pierre-Dominique ; Mockenhaupt, Maja...
Journal of the American Academy of Dermatology. 58 (2008) 1 - p. 25-32 , 2008

Link: https://doi.org/10.1016/..